Filing Details
- Accession Number:
- 0001415889-25-019667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-11 16:04:11
- Reporting Period:
- 2025-07-09
- Filing Date:
- 2025-07-11
- Accepted Time:
- 2025-07-11 16:04:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1818331 | Genedx Holdings Corp. | WGS | Services-Health Services (8000) | 851966622 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1944119 | Kevin Feeley | C/O Genedx Holdings Corp. 333 Ludlow St, North Tower, 6Th Floor Stamford CT 06902 | Chief Financial Officer | No | No | No | No |
Transaction Summary
Sold: | 5,278 shares | Avg. Price: $93.00 | Total Value: $490,854.00 |
Number of Shares After Transactions: | 3,392 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2025-07-09 | 1,245 | $32.67 | 8,670 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2025-07-09 | 5,278 | $93.00 | 3,392 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2025-07-09 | 1,245 | $0.00 | 1,245 | $32.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,228 | 2032-08-31 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.
- Following the reported sales and option exercise, in addition to the 3,392 shares of Class A common stock and the option to purchase up to 6,228 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 135,762 shares of Class A common stock and additional options to purchase up to an aggregate of 20,924 shares of Class A common stock, which RSUs and options vest according to their respective terms.
- 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.